TREPROSTINIL | N022387 | UNITED THERAPEUTICS CORP
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2016-00006 | 8497393Delisted | IPR | SteadyMed Ltd. et al. | Final Written Decision | 2015-10-02 | — |
| IPR2017-01622 | 9339507 | IPR | Watson Laboratories, Inc. | Terminated-Settled | 2017-06-21 | — |
| IPR2017-01621 | 9358240 | IPR | Watson Laboratories, Inc. | Terminated-Settled | 2017-06-21 | — |
| IPR2020-00769 | 9593066 | IPR | Liquidia Technologies, Inc. | Institution Denied | 2020-03-30 | — |
| IPR2020-00770 | 9604901Delisted | IPR | Liquidia Technolgies, Inc. | Final Written Decision | 2020-03-30 | 2024-08-20 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2023-09-05 | Active | — | |
| D. Del. | 2020-06-04 | Terminated 2022-09-09 | — | |
UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. 5 patentsANDA 208172treprostinil | D.N.J. | 2015-07-22 | Terminated 2018-09-18 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Hogan Lovells US LLP (United Therapeutics Corporation (UT) FDA-2016-P-2478 United Therapeutics Corporation, through counsel Hogan Lovells US LLP, filed this citizen petition on August 10, 2016, requesting that the FDA refrain from approving any Abbreviated New Drug Application (ANDA) for generic treprostinil inhalation solution referencing Tyvaso unless the proposed generi | 505(q) | 2016-08-11 | Denied | Hogan Lovells US LLP (United Therapeutics Corporation (UT) |
Source: Regulations.gov. FDA citizen petitions matched by application number.